ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,087,665 | +68.4% | 52,191 | +93.5% | 0.00% | +100.0% |
| Q2 2023 | $645,853 | +40.5% | 26,967 | +10.4% | 0.00% | 0.0% |
| Q1 2023 | $459,704 | +49.4% | 24,426 | +26.3% | 0.00% | 0.0% |
| Q4 2022 | $307,767 | +48.7% | 19,333 | +52.5% | 0.00% | – |
| Q3 2022 | $207,000 | +15.6% | 12,677 | -3.6% | 0.00% | – |
| Q2 2022 | $179,000 | -94.3% | 13,154 | -89.8% | 0.00% | -100.0% |
| Q1 2022 | $3,116,000 | -12.7% | 128,607 | -15.9% | 0.01% | -14.3% |
| Q4 2021 | $3,570,000 | +39.6% | 152,879 | -0.9% | 0.01% | +40.0% |
| Q3 2021 | $2,558,000 | -33.2% | 154,301 | -1.7% | 0.01% | -37.5% |
| Q2 2021 | $3,831,000 | -18.1% | 157,013 | -4.7% | 0.01% | -33.3% |
| Q1 2021 | $4,675,000 | -18.5% | 164,792 | +53.0% | 0.01% | -20.0% |
| Q4 2020 | $5,733,000 | +68.6% | 107,697 | +30.4% | 0.02% | +50.0% |
| Q3 2020 | $3,401,000 | -30.4% | 82,601 | -18.0% | 0.01% | -33.3% |
| Q2 2020 | $4,884,000 | +5.6% | 100,755 | -8.0% | 0.02% | -11.8% |
| Q1 2020 | $4,627,000 | +6.3% | 109,462 | +7.6% | 0.02% | +30.8% |
| Q4 2019 | $4,352,000 | +16.0% | 101,732 | -2.5% | 0.01% | +30.0% |
| Q3 2019 | $3,753,000 | +62.7% | 104,300 | +20.9% | 0.01% | +25.0% |
| Q2 2019 | $2,306,000 | +13.7% | 86,260 | +14.2% | 0.01% | +14.3% |
| Q1 2019 | $2,028,000 | +2128.6% | 75,549 | +1624.5% | 0.01% | – |
| Q4 2018 | $91,000 | -71.2% | 4,381 | -70.5% | 0.00% | -100.0% |
| Q3 2018 | $316,000 | -58.7% | 14,831 | -70.4% | 0.00% | -66.7% |
| Q2 2018 | $766,000 | +3547.6% | 50,107 | +5247.6% | 0.00% | – |
| Q1 2018 | $21,000 | -96.9% | 937 | -95.8% | 0.00% | -100.0% |
| Q4 2017 | $667,000 | -9.5% | 22,161 | +13.2% | 0.00% | -33.3% |
| Q3 2017 | $737,000 | +55.2% | 19,571 | +15.1% | 0.00% | +50.0% |
| Q2 2017 | $475,000 | -48.5% | 17,006 | -36.6% | 0.00% | -50.0% |
| Q1 2017 | $923,000 | +188.4% | 26,837 | +142.2% | 0.00% | +100.0% |
| Q4 2016 | $320,000 | -87.2% | 11,082 | -85.9% | 0.00% | -84.6% |
| Q3 2016 | $2,505,000 | +37.6% | 78,740 | +40.4% | 0.01% | +18.2% |
| Q2 2016 | $1,820,000 | +116.4% | 56,077 | +86.4% | 0.01% | +120.0% |
| Q1 2016 | $841,000 | -32.2% | 30,077 | -13.6% | 0.01% | -37.5% |
| Q4 2015 | $1,240,000 | -41.9% | 34,814 | -46.1% | 0.01% | -60.0% |
| Q3 2015 | $2,135,000 | +84.8% | 64,536 | +134.1% | 0.02% | +100.0% |
| Q2 2015 | $1,155,000 | +20.7% | 27,571 | -6.1% | 0.01% | +25.0% |
| Q1 2015 | $957,000 | -17.5% | 29,366 | -19.6% | 0.01% | -20.0% |
| Q4 2014 | $1,160,000 | – | 36,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |